Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Monte Rosa Therapeutics Q2 EPS $(0.57) Up From $(3.63) YoY

Monte Rosa Therapeutics (NASDAQ:GLUE) reported quarterly losses of $(0.57) per share. This is a 84.3 percent increase over losses of $(3.63) per share from the same period last year.
byBenzinga Newsdesk
August 11, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Monte Rosa Therapeutics (NASDAQ:GLUE) reported quarterly losses of $(0.57) per share. This is a 84.3 percent increase over losses of $(3.63) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts